Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib

Details for Australian Patent Application No. 2005245572 (hide)

Owner Ludwig Institute for Cancer Research Uppsala University Hospital Nister, M.

Inventors Ostman, Arne; Hagerstrand, Daniel; Hesselager, Goran; Nister, Monica

Agent Davies Collison Cave

Pub. Number AU-B-2005245572

PCT Pub. Number WO2005/113801

Priority 0425257.3 16.11.04 GB; 0410883.3 14.05.04 GB

Filing date 13 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 4 December 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/113801 Priority application(s): WO2005/113801

4 December 2008 Application Accepted

  Published as AU-B-2005245572

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245580-2-substituted pyrimidines and their use as pesticides

2005245571-Wind power installation having an auxiliary generator and method for the control thereof